#16
|
|||
|
|||
Åùå ðàç îãðîìíîå ñïàñèáî, Èãîðü Àëåêñàíäðîâè÷.
|
#17
|
|||
|
|||
Çäðàâñòâóéòå!
Ìàëü÷èê, ïî÷òè 6 ëåò. Ïðåäñòîèò ïëàíîâàÿ ðåâàêöèíàöèÿ ïðîòèâ êîðè-êðàñíóõè-ïàðîòèòà. Ñêàæèòå, ïîæàëóéñòà, ìîæíî ëè îäíîâðåìåííî ñ íåé ñäåëàòü ðåâàêöèíàöèþ ÀÄÑ-Ì?  êàëåíäàðå çíà÷èòñÿ, ÷òî ïðèâèâêà äåëàåòñÿ â 6-7 ëåò. Êîãäà âñå æå ëó÷øå? |
#18
|
|||
|
|||
Çäðàâñòâóéòå! Ðåáåíîê 6,5 ëåò. Ïîäîøëî âðåìÿ ðåâàêöèíàöèè îò ñòîëáíÿêà è äèôòåðèè (ðîâíî 5 ëåò ñ ïîñëåäíåé ÀÊÄÑ).  ïîëèêëèíèêå åñòü òîëüêî ÀÄÑ-Ì. Õîòåëà áû ñäåëàòü ðåáåíêó "Àäàñåëü", íî â ãîðîäå åå íåò è íåèçâåñòíî, êîãäà áóäåò. Ñêàæèòå, ïîæàëóéñòà, åñòü ëè ñìûñë æäàòü "Àäàñåëü"(âîçìîæíî, ïî ñëîâàì, âðà÷åé ïîÿâèòñÿ ïîñëå Íîâîãî Ãîäà) èëè ëó÷øå ñäåëàòü ÀÄÑ-Ì â ñâîé ñðîê?
|
#19
|
||||
|
||||
Çäðàâñòâóéòå!
Íè÷åãî êðèòè÷íîãî â "ïîòåðå" ïàðû ìåñÿöåâ íåò. Åñëè Àäàñåëü ïîÿâèòñÿ ñòîèò ñäåëàòü å¸. Åñëè íå ïîÿâèòñÿ - ñïîêîéíî ñäåëàåòå ÀÄÑ-Ì. Åù¸ âàðèàíò - Èíôàíðèêñ - ñåé÷àñ ðàçðåø¸í äî 7 ëåò ïî îáíîâëåííîé èíñòðóêöèè.
__________________
Ñ óâàæåíèåì, Èãîðü Àëåêñàíäðîâè÷ |
#20
|
|||
|
|||
Çäðàâñòâóéòå! Ìàëü÷èê, 6 ëåò è 9 ìåñÿöåâ. Ñåãîäíÿ áûëà ïðîâåäåíà ðåâàêöèíàöèÿ îò êëåùåâîãî ýíöåôàëèòà ("Êëåù-Ý-Âàê"), è ñäåëàíà ïåðâàÿ ïðèâèâêà "Âàðèëðèêñ". Âðà÷, êîòîðàÿ ïðîâîäèëà îñìîòð, ñêàçàëà, ÷òî âòîðóþ ïðèâèâêó íóæíî ñäåëàòü ÷åðåç 6 íåäåëü (ñ âàêöèíîé ñåé÷àñ íàïðÿæåíêà, íî, ðàç áóäåò âòîðàÿ ïðèâèâêà, íàì îòëîæàò).
Ñêàæèòå, ïîæàëóéñòà, òàê ìîæíî ñäåëàòü? èëè âñå æå ëó÷øå ÷åðåç 3 ìåñÿöà? È âòîðîé íþàíñ. Äîìà, çàñîìíåâàâøèñü â ñðîêàõ, ÿ åùå ðàç âíèìàòåëüíî ïåðå÷èòàëà èíñòðóêöèþ è îáíàðóæèëà, ÷òî áûëà íàðóøåíà òåõíèêà ïðîâåäåíèÿ âàêöèíàöèè. Ìåäñåñòðà, ïîñëå îáðàáîòêè êîæè àíòèñåïòèêîì, ââåëà âàêöèíó ñðàçó æå, íå äîæèäàÿñü âûñûõàíèÿ ñïèðòà. Ïîñëå ÷åãî ýòó ñàëôåòêó (ñïèðòîâóþ) åùå è ïðèëîæèëà ê ðóêå ðåáåíêà. Äåðæàëè ìû åå ïðàâäà ñîâñåì íåäîëãî (êàê òîëüêî âûøëè èç êàáèíåòà, âûêèíóëè). Ñêàæèòå, ïîæàëóéñòà, ìîæíî ëè âîîáùå "çàñ÷èòûâàòü" äàííóþ âàêöèíàöèþ "Âàðèëðèêñîì"? |
#21
|
||||
|
||||
1. Ìîæíî
2. Çàñ÷èòûâàåòñÿ
__________________
Ñ óâàæåíèåì, Èãîðü Àëåêñàíäðîâè÷ |
#22
|
|||
|
|||
Ñïàñèáî áîëüøîå!
|
|
#23
|
|||
|
|||
Çäðàâñòâóéòå! Ìàëü÷èê, 9 ëåò è 6 ìåñÿöåâ, ïðèâèò ïî âîçðàñòó+ñâåðõ êàëåíäàðÿ.
Ñîáèðàþñü ïîñòàâèòü ðåáåíêó "Ãàðäàñèë". Â ïîëèêëèíèêå ïðåäóïðåäèëè, ÷òî ñ âàêöèíàìè âîçìîæåí ïåðåáîé (íå ôàêò, ÷òî âòîðàÿ äîçà áóäåò âîâðåìÿ). Ïðèâèâêà äîðîãàÿ. Â ñâÿçè ñ ýòèì âîïðîñû: 1. Åñòü ëè ñìûñë äåëàòü âàêöèíó, åñëè ãðàôèê âàêöèíàöèè âîçìîæíî áóäåò íàðóøåí? 2. Ìîæíî ëè äåëàòü "Ãàðäàñèë" îäíîâðåìåííî ñ "Êëåù-Ý-Âàê"? |
#24
|
|||
|
|||
1) åñëè óëîæèòåñü ñ òðåìÿ èíúåêöèÿìè â ãîä, òî åñòü ñìûñë
2) ìîæíî Ïî ÎÌÑ ãàðäàñèë? |
#25
|
|||
|
|||
Çäðàâñòâóéòå! Íåò, íå ïî ÎÌÑ, çà ñâîé ñ÷¸ò.
À ðàçâå ñ 9 äî 13 ëåò íå äâå äîçû? |
#26
|
||||
|
||||
Ãàðäàñèë ïðè ñõåìå â 2 ïðèâèâêè 2ÿ ïðèâèâêà äåëàåòñÿ ÷åðåç 6 ìåñÿöåâ ïîñëå ïåðâîé(ìèíèìàëüíûé èíòåðâàë ìîæåò áûòü ñîêðàøåí äî 5 ìåñÿöåâ).Íî â êàæäîé ñòðàíå ñõåìû ìîãóò íåìíîãî îòëè÷àòüñÿ
Åñëè ñõåìà â òðè ïðèâèâêè; 2ÿ äåëàåòñÿ ÷åðåç 2 ìåñ. ïîñëå ïåðâîé è 3-ÿ ÷åðåç 6 ìåñÿöåâ ïîñëå 1-é ïðèâèâêè |
#27
|
|||
|
|||
|
#28
|
||||
|
||||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
For individuals 9 through 14 years of age, GARDASIL 9 can be administered using a 2-dose or 3-dose schedule. For the 2-dose schedule, the second dose should be administered 6–12 months after the first dose. If the second dose is administered less than 5 months after the first dose, a third dose should be given at least 4 months after the second dose. For the 3-dose schedule, GARDASIL 9 should be administered at 0, 2 months, and 6 months. For individuals 15 through 45 years of age, GARDASIL 9 is administered using a 3-dose schedule at 0, 2 months, and 6 months. |
#29
|
|||
|
|||
Áëàãîäàðþ!
Íî ó íàñ 9-âàëåíòíóþ ïîêà íå âèäåëà.  Ìóðìàíñêå, ó÷èòûâàÿ áëèçîñòü Êèòàÿ, âñ¸ ìîæåò áûòü. Äëÿ 4-õ òàê æå? |
#30
|
||||
|
||||
Öèòàòà:
Individuals 9 to and including 13 years of age Gardasil can be administered according to a 2-dose schedule (0.5 ml at 0, 6 months) (see section 5.1). If the second vaccine dose is administered earlier than 6 months after the first dose, a third dose should always be administered. 3 Alternatively, Gardasil can be administered according to a 3-dose (0.5 ml at 0, 2, 6 months) schedule. The second dose should be administered at least one month after the first dose and the third dose should be administered at least 3 months after the second dose. All three doses should be given within a 1-year period. Individuals 14 years of age and older Gardasil should be administered according to a 3-dose (0.5 ml at 0, 2, 6 months) schedule. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |